INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
The collaboration, aimed at co-development of technology platforms of both the companies, will initially focus on areas concerning bio-derived production of butadiene.
INVISTA Intermediates president Warren Primeaux said, "We anticipate this collaboration with SilicoLife will help us accelerate our timeline to develop new bio-derived processes for a range of industrial chemicals -- helping us further improve our cost and sustainability position in this area."
In the process of developing new bio-based routes to industrial chemicals, the agreement will make use of biotechnology and catalysis, and knowledge of the chemicals industry, and SilicoLife's in silico metabolic engineering and rational synthetic biology capabilities.
SilicoLife CEO Sim o Soares said, "The collaboration with INVISTA combines our state-of-the-art engineering expertise with INVISTA's world-class research team to accelerate the design of optimized microbial strains for the cost-effective production of industrial chemicals from renewable feedstocks."
